[Federal Register Volume 87, Number 67 (Thursday, April 7, 2022)]
[Notices]
[Page 20389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07367]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-80-2021]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Authorization 
of Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk Drug 
Substance), Andover, Massachusetts

    On December 3, 2021, Wyeth Pharmaceuticals, LLC submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 27R, in Andover, Massachusetts.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 70439, December 10, 2021). On 
April 4, 2022, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
section 400.14.

    Dated: April 4, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-07367 Filed 4-6-22; 8:45 am]
BILLING CODE 3510-DS-P